Bristol Myers Squibb

Senior Director, US Medical Cell Therapy, Multiple Myeloma

Madison - Giralda - NJ - US · Director · Part-time

Sponsorship not specified$229k-$278kDetected 6 hours ago

ExcelClinical TrialsBioinformaticsMolecular BiologyResearchLeadershipCommunicationCollaborationMentoring

About the role

This role carries dual accountability: driving the commercial launch excellence of Arlo cel and stewarding the ongoing lifecycle management of Abecma, while maintaining a forward-looking lens on the broader MM Cell Therapy pipeline.
The role requires the depth of scientific expertise, credibility with our external thought leaders, and the leadership composure to operate effectively at the intersection of US commercialization, WW Medical Affairs, and global Clinical Development.
This is a high-visibility, high-impact role at a pivotal moment in the evolution of BMS's Cell Therapy franchise, demanding an individual who can balance strategic vision with flawless operational execution in a complex, matrixed environment.

Serve as a credible, senior-level external representative of BMS in MM Cell Therapy - engaging thought leaders, cooperative groups, steering committees, and advisory boards to generate insights, shape the evolving treatment paradigm, and drive appropriate adoption of BMS medicines at major academic and community institutions.
Manage, coach, and develop direct reports, establishing clear goals, driving accountability, and cultivating a culture of scientific excellence, urgency, and inclusion consistent with BMS values.
Proven track record of operating effectively within complex, matrixed WW and US cross-functional organizations; demonstrated ability to influence without authority and build alignment across diverse stakeholders.
Established relationships with MM thought leaders and KOLs at major academic centers; demonstrated ability to build and sustain credible external scientific partnerships.
Proven people leadership: experience building, coaching, and developing high-performing teams across direct and indirect reporting structures.
High operational acumen: ability to manage multiple complex priorities in a deadline-driven environment with measurable accountability for outcomes.
Lead bidirectional alignment between global strategy and US execution, and provide strategic US input into pipeline development, trial design, and evidence priorities across the MM Cell Therapy portfolio.
Drive Cross-Functional Integration with a OneBMS Approach.

Executive-level communication skills - oral, written, and presentation - with the ability to represent BMS credibly with both external experts and senior internal leadership.
Proficiency in scientific and clinical data review and interpretation
Regular travel required (up to 40%)
The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee's work schedule, job-related knowledge, and experience.
Strong understanding of market access, payer dynamics, and the commercialization process as they apply to specialty/cell therapy products.
Deep expertise in Multiple Myeloma required; direct experience with CAR-T or Cell Therapy modalities strongly preferred.

160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.

Define and lead the integrated US Medical Affairs plan across the Multiple Myeloma Cell Therapy franchise in full alignment with US Commercialization and WW Medical strategies.
Translate global direction into differentiated, market-ready US medical execution.
Function as a senior core member of the Worldwide MM Asset Indication Medical Strategy (AIMS) team, ensuring US market insights actively shape global strategy.
Provide perspectives to the MM Cell Therapy data generation strategy and ensure execution of the US Medical Evidence Generation portfolio.
Partner with Medical Evidence Generation, Clinical Development, and WW colleagues to close evidence gaps and advance the integrated evidence plan across marketed products and pipeline assets.
Demonstrated experience leading US Medical Affairs for a major product launch or lifecycle management program; CAR-T or cell therapy launch experience is a significant differentiator.
Medical, pharmacy, dental, and vision care.
Work-life benefits include:

This listing is sourced directly from Bristol Myers Squibb's careers page and normalized into a canonical job model.